Last updated 2026-06-18
- Raised $6.5M funding round, Jan 2016
- Raised $4M funding round, Oct 2014
- Raised funding round, Mar 2018
Total raised
$10.5M
Last: 2018-03
Stage
Series B
Founded
2013
Headcount
4
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
SmartZyme Biopharma develops novel enzymesfor a variety of medical applications. Based on its proprietary proteinengineering platform, the Provolution, the companydesigns enzymes for improved clinical performanceby engineering them for efficacy and safety. Initially, SmartZyme is focusing on products for diabetes patients, including glucose monitoring test strips and patches. TheProvolution system combines advanced computationalmethods with a random mutagenesis approach, processingmultiple protein characteristics that are required for optimalperformance.
Funding history · 3 rounds · $10.5M total
2018-03
Undisclosed
2016-01
2014-10
$4.0M
Q&A
- What is the current status of SmartZyme Biopharma?
- SmartZyme Biopharma is currently inactive, having ceased operations in August 2024.
- What is SmartZyme Biopharma's primary focus?
- SmartZyme Biopharma focuses on improving enzymes for glucose monitoring and developing novel enzymes for various medical applications, particularly for diabetes patients.
- What is the total amount of funding SmartZyme Biopharma has raised?
- SmartZyme Biopharma has raised a total of $10,500,000.
- When was SmartZyme Biopharma founded?
- SmartZyme Biopharma was founded in November 2013.
- Which investors participated in SmartZyme Biopharma's funding rounds?
- Investors in SmartZyme Biopharma's funding rounds include OrbiMed and OrbiMed Healthcare Fund Management
- What is SmartZyme Biopharma's proprietary technology platform?
- SmartZyme Biopharma's proprietary technology platform is called Provolution, which combines advanced computational methods with a random mutagenesis approach for enzyme engineering.
- How many employees does SmartZyme Biopharma have?
- SmartZyme Biopharma has 1-10 employees.
- Where is SmartZyme Biopharma headquartered?
- SmartZyme Biopharma is headquartered in Ness Ziona, Center District, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Highlights
1 PatentsVerified
Tags
wearablediabetesbioinformaticschronic-patientswearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | smzyme.com/ |
|---|---|
| linkedin.com/company/4857689 |
Identifiers & details
| Founded | 2013-11 |
|---|---|
| Employees (exact) | 4 |
| Status reason | Non Active, Aug 2024 ceased to operate |